Navigation Links
U Alberta researcher in same group as Darwin and Hawking
Date:7/6/2009

EdmontonJohn Vederas, a University of Alberta professor in the department of chemistry, has been named to the Royal Society, the national academy of science of the United Kingdom and the Commonwealth. The ceremony takes place the week of July 6 in London.

Included in the Royal Society's membership are Isaac Newton, Charles Darwin and Stephen Hawking. There are more than 60 Nobel laureates among the society's 1,400 members.

Vederas is being recognized for a body of research that centers on the identification of antibiotic peptides in bacteria. Antibiotic peptides play an important role in food preservation and may have potential for human use, such as combating hospital-acquired infections. Peptides are 1,000 to 1 million times more active than conventional antibiotics and are effective against infectious bacteria resistant to commonly used antibiotics. Currently, more than 50 per cent of hospital-acquired infections are resistant to common antibiotics. Veredas' work also centres around biosynthesis by fungi of important metabolites including cholesterol-lowering drugs such as statins.

"The appointment is a great honour and I was very surprised and pleased," said Vederas. "The Royal Society has many programs to advise and assist scientists and government policy makers, as well as promote understanding science by the general public. I certainly plan to participate in some of these activities as a new fellow of the Royal Society."

Vederas joined the University of Alberta in 1977. He obtained a bachelor of science degree from Stanford University and a PhD from the Massachusetts Institute of Technology. Vederas has received several awards for research and teaching at the U of A. He has written more than 235 research publications and has created 13 patents.


'/>"/>

Contact: Brian Murphy
brian.murphy@ualberta.ca
780-492-6041
University of Alberta
Source:Eurekalert

Page: 1

Related biology news :

1. University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
2. Ancient reptile rises from Alberta oil sands
3. A new dinosaur species, Pachyrhinosaur lakustai, unveiled from Pipestone Creek, Alberta, Canada
4. New dinosaur species possible in Northwestern Alberta
5. Researchers identify proteins involved in new neurodegenerative syndrome
6. Texas researchers and educators head for Antarctica
7. MGH researchers describe new way to identify, evolve novel enzymes
8. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
9. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
10. U of MN researchers discover noninvasive diagnostic tool for brain diseases
11. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading producer ... Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 ... form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... NY (PRWEB) , ... January 18, 2017 , ... Researchers from a new study ... do not fall low enough after prostate cancer treatment, this indicates there is still remaining ... risk of mortality. , “ The PSA test has always been an indicator of whether ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
Breaking Biology Technology: